Max Hoffer
Impact in
- Organic Chemistry top 10%
- Carbohydrate Chemistry and Synthesis
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Click Chemistry and Applications
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- Bioactive Compounds and Antitumor Agents 1
-
- Synthesis and Characterization of Heterocyclic Compounds 4
- Synthesis and biological activity 2
- Synthesis of heterocyclic compounds 1
- Co-authors
- E. GrunbergJack J. FoxR. U. LemieuxNaishun C. YungRobert DuschinskyA. BROSSIIris WempenV. Toome
- Journals
- Journal of Medicinal Chemistry (6 papers)Journal of the American Chemical Society (2 papers)Canadian Journal of Chemistry (1 paper)Chemische Berichte (1 paper)Journal of Heterocyclic Chemistry (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Max Hoffer
12 papers receiving 529 citations
Peers
Comparison fields: 5 of 61
- Organic Chemistry 313
- Infectious Diseases 141
- Pharmaceutical Science 36
- Molecular Biology 377
- Physiology 21
Countries citing papers authored by Max Hoffer
This map shows the geographic impact of Max Hoffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Hoffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Hoffer more than expected).
Fields of papers citing papers by Max Hoffer
This network shows the impact of papers produced by Max Hoffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Hoffer. The network helps show where Max Hoffer may publish in the future.
Co-authorship network
The 19 scholars most cited alongside Max Hoffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 47 | |
| 2 | 1971 | 11 | |
| 3 | 1971 | 8 | |
| 4 | 1971 | 7 | |
| 5 | Antihistomonal activity of 1,2-disubstituted 5-nitroimidazoles. | 1968 | 9 |
| 6 | 1967 | 31 | |
| 7 | 1966 | 22 | |
| 8 | 1966 | 6 | |
| 9 | 1961 | 45 | |
| 10 | 1961 | 37 | |
| 11 | 1960 | 315 | |
| 12 | 1959 | 48 |
About Max Hoffer
Max Hoffer is a scholar working on Toxicology, Organic Chemistry, Physical and Theoretical Chemistry, Molecular Biology and Spectroscopy, having authored 12 papers that have together received 586 indexed citations. Recurring topics across this work include Synthesis and Characterization of Heterocyclic Compounds (4 papers), DNA and Nucleic Acid Chemistry (3 papers), Synthesis and biological activity (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Cancer therapeutics and mechanisms (1 paper), Synthesis of heterocyclic compounds (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Organic Chemistry (313 citations), Infectious Diseases (141 citations), Pharmaceutical Science (36 citations), Molecular Biology (377 citations) and Physiology (21 citations). Max Hoffer has collaborated with scholars based in United States and Switzerland. Frequent co-authors include E. Grunberg, Jack J. Fox, R. U. Lemieux, Naishun C. Yung, Robert Duschinsky, A. BROSSI, Iris Wempen, V. Toome, Arnold Brossi and Joseph H. Burchenal. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of the American Chemical Society, Canadian Journal of Chemistry, Chemische Berichte and Journal of Heterocyclic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.